Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Stock Quote Today & Recent News 2Seventy Bio Inc TSVT

Healthcare Biotechnology
2seventy bio, Inc. is a cell and gene therapy company focused on the research, development, and commercialization of transformative treatments for cancer. The Company is focused on the commercialization and development of Abecma (idecabtagene vicleucel). Abecma is its B cell maturation antigen (BCMA)-targeted CAR T cell therapy for multiple myeloma, in collaboration with their partner Bristol... see more
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >

Current News (NDAQ:TSVT)

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of 2seventy bio, Inc. - TSVT

Accesswire 6 days ago

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of 2seventy bio, Inc. - TSVT

Accesswire 8 days ago

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of 2seventy bio, Inc. - TSVT

Accesswire 10 days ago

2seventy bio Reports Third Quarter Financial Results and Recent Operational Progress

Business Wire 10 days ago

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of 2seventy bio, Inc. - TSVT

PR Newswire 12 days ago

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of 2seventy bio, Inc. - TSVT

Accesswire November 8, 2024

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of 2seventy bio, Inc. - TSVT

Accesswire November 6, 2024

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of 2seventy bio, Inc. - TSVT

Accesswire November 4, 2024

2seventy bio to Report Third Quarter 2024 Financial Results and Participate in Upcoming Investor Conference

Business Wire November 4, 2024
View More News ››

Opinion & Analysis (NDAQ:TSVT)

No current opinion is available.
View More Opinion ››

Bullboard Posts (NDAQ:TSVT)

Bronstein, Gewirtz & Grossman, LLC Is Investigating 2seventy

Breaking News: $TSVT Bronstein, Gewirtz & Grossman, LLC Is Investigating 2seventy bio, Inc. (TSVT) And Encourages Stockholders to...
whytestocks - September 26, 2024

2seventy bio Provides Update on KarMMa-9 Study and Previews

News; $TSVT 2seventy bio Provides Update on KarMMa-9 Study and Previews Anticipated Strong Third Quarter Revenue Performance2seventy and...
whytestocks - September 25, 2024

2seventy bio, Inc. (TSVT): Laser-Focused on Abecma Commercia

http://beyondspx.com/2024/08/01/2seventy-bio-inc-tsvt-laser-focused-on-abecma-commercialization-after-strategic-realignment/
MikeTester - August 1, 2024

Novo Nordisk Buys 2seventy's Hemophilia A Program, Divestitu

JUST IN: $TSVT Novo Nordisk Buys 2seventy's Hemophilia A Program, Divestiture Supports Exclusive Focus On Abecma | BenzingaOn...
whytestocks - June 27, 2024

Hedge Fund Stock Price Manipulation?

Hedge Funds Weigh In On 2seventy bio A number of institutional investors have recently bought and sold shares of TSVT. Goldman Sachs...
javaman12 - June 8, 2024

2seventy bio Announces New Strategic Path Forward

News; $TSVT 2seventy bio Announces New Strategic Path Forward- Company to focus exclusively on commercialization and development of...
whytestocks - January 30, 2024
View more Bullboard ››

Laurion Mineral Exploration Inc.

Laurion Mineral Exploration Inc.

Laurion Mineral Exploration Inc. is a Canada-based mid-stage junior exploration and development company. The Company is ...
View More »